NEW: 请通过本地经销商订购 4A Biotech Co.,Ltd.

ApoSAA (Active) 蛋白

ABIN413038 产品详细信息, 供应商: Log in to see
蛋白名称
宿主

2
资源
大肠杆菌(E. Coli)
2
蛋白类型
Recombinant
生物活性
Active
应用范围
High Pressure Liquid Chromatography (HPLC), SDS-PAGE (SDS)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

纯度 ≥98 % by SDS-PAGE
≥98 % by HPLC
内毒素水平 <0.1 ng/μg
ProductDetails: Biological Activity Comment For most in vitro applications, apo-SAA exerts its biological activity in the concentration range of 10-50 μg/ml.
背景 Human apo-SAA is a 104 amino acid polypeptide that circulates primarily in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 μg/mL in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid polypeptide, which contains an 18 amino acid N-terminal signal sequence.

Alternative Names: Serum amyloid A protein, SAA, Amyloid protein A, Amyloid fibril protein AA, Apolipoprotein, apolipoproteins, SAA1, SAA2, PIG4, TP53I4, MGC111216,
分子量 11.5 kDa
基因ID 6288
UniProt P0DJI8
应用备注 Optimal working dilution should be determined by the investigator.
限制 仅限研究用
状态 Lyophilized
溶解方式 Reconstitute in 0.1 % acetic acid to a concentration of 1 μg/μl. This solution can then be diluted into other aqueous buffers.
缓冲液 Lyophilized with no additives
注意事项 Centrifuge the vial prior to opening.
储存条件 -20 °C
有效期 12 months
厂商提供的图像
Western Blotting (WB) image for ApoSAA (Active) 蛋白 (ABIN413038) ApoSAA (Active) protein
有引用在: Fleischer, Rossignol, Francis, Chan, Lynn, Wasan: "Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins." in: Innate immunity, Vol. 18, Issue 1, pp. 171-8, 2012 (PubMed).

Wilson, Thompson, Webb, de Beer, King, Tannock: "Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner." in: The American journal of pathology, Vol. 173, Issue 6, pp. 1902-10, 2008 (PubMed).

Cai, Cai, Jiang, Chang, van der Westhuyzen, Luo: "Human serum amyloid A protein inhibits hepatitis C virus entry into cells." in: Journal of virology, Vol. 81, Issue 11, pp. 6128-33, 2007 (PubMed).

El Kebir, József, Khreiss, Pan, Petasis, Serhan, Filep: "Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 1, pp. 616-22, 2007 (PubMed).